This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nam, J.-S. Articles by Wakefield, L. M. Search for Related Content PubMed PubMed Citation Articles by Nam, J.-S. Articles by Wakefield, L. M.

Transforming Growth Factor β Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17

¹ Lee Gil Ya Cancer and Diabetes Institute, Gachon University of Medicine and Science, Incheon, Korea; ² Laboratory of Cancer Biology and Genetics; ³ Vaccine Branch, National Cancer Institute; and ⁴ Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland; and ⁵ Genzyme Corp, Framingham, Massachusetts

Requests for reprints: Lalage Wakefield, National Cancer Institute, Building 37, Room 4032A, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255. Phone: 301-496-8351; Fax: 301-496-8709; E-mail: lw34g{at}nih.gov.

Key Words: IL-17TGF-β • immune surveillance • cancer • mouse models

Overexpression of the immunosuppressive cytokine transforming growth factor β (TGF-β) is one strategy that tumors have developed to evade effective immunesurveillance. Using transplantable models of breast and colon cancer, we made the unexpected finding that CD8+ cells in tumor-bearing animals can directly promote tumorigenesis, by a mechanism that is dependent on TGF-β. We showed that CD8+ splenocytes from tumor-bearing mice expressed elevated interleukin (IL)-17 when compared with naive mice, and that CD8+ T cells could be induced to make IL-17 on addition of TGF-β and IL-6 in vitro. Treatment of mice with anti–TGF-β antibodies in vivo reduced IL-17 expression both in the tumor and the locoregional lymph nodes. Although IL-17 has not previously been shown to act as a survival factor for epithelial cells, we found that IL-17 suppressed apoptosis of several tumor cell lines in vitro, suggesting that this altered T-cell polarization has the potential to promote tumorigenesis directly, rather than indirectly through inflammatory sequelae. Consistent with this hypothesis, knockdown of the IL-17 receptor in 4T1 mouse mammary cancer cells enhanced apoptosis and decreased tumor growth in vivo. Thus, in addition to suppressing immune surveillance, tumor-induced TGF-β may actively subvert the CD8+ arm of the immune system into directly promoting tumor growth by an IL-17–dependent mechanism. [Cancer Res 2008;68(10):3915–23]

This article has been cited by other articles:

				R. Ueda, M. Fujita, X. Zhu, K. Sasaki, E. R. Kastenhuber, G. Kohanbash, H. A. McDonald, J. Harper, S. Lonning, and H. Okada Systemic Inhibition of Transforming Growth Factor-{beta} in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines Clin. Cancer Res., November 1, 2009; 15(21): 6551 - 6559. [Abstract] [Full Text] [PDF]

				M. Terabe, E. Ambrosino, S. Takaku, J. J. O'Konek, D. Venzon, S. Lonning, J. M. McPherson, and J. A. Berzofsky Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor-{beta} Monoclonal Antibody Clin. Cancer Res., November 1, 2009; 15(21): 6560 - 6569. [Abstract] [Full Text] [PDF]

				G. Murugaiyan and B. Saha Protumor vs Antitumor Functions of IL-17 J. Immunol., October 1, 2009; 183(7): 4169 - 4175. [Abstract] [Full Text] [PDF]

				P. Muranski and N. P. Restifo Does IL-17 promote tumor growth? Blood, July 9, 2009; 114(2): 231 - 232. [Full Text] [PDF]

				L. Wang, T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway J. Exp. Med., July 6, 2009; 206(7): 1457 - 1464. [Abstract] [Full Text] [PDF]

				E. Gounaris, N. R. Blatner, K. Dennis, F. Magnusson, M. F. Gurish, T. B. Strom, P. Beckhove, F. Gounari, and K. Khazaie T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis Cancer Res., July 1, 2009; 69(13): 5490 - 5497. [Abstract] [Full Text] [PDF]

				Z.-Z. Yang, A. J. Novak, S. C. Ziesmer, T. E. Witzig, and S. M. Ansell Malignant B Cells Skew the Balance of Regulatory T Cells and TH17 Cells in B-Cell Non-Hodgkin's Lymphoma Cancer Res., July 1, 2009; 69(13): 5522 - 5530. [Abstract] [Full Text] [PDF]

				X. Yuan, M. J. Ansari, F. D'Addio, J. Paez-Cortez, I. Schmitt, M. Donnarumma, O. Boenisch, X. Zhao, J. Popoola, M. R. Clarkson, et al. Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells PNAS, June 30, 2009; 106(26): 10734 - 10739. [Abstract] [Full Text] [PDF]

				S. Guo, D. Cobb, and R. B. Smeltz T-bet Inhibits the In Vivo Differentiation of Parasite-Specific CD4+ Th17 Cells in a T Cell-Intrinsic Manner J. Immunol., May 15, 2009; 182(10): 6179 - 6186. [Abstract] [Full Text] [PDF]

				B. Ciric, M. El-behi, R. Cabrera, G.-X. Zhang, and A. Rostami IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells J. Immunol., May 1, 2009; 182(9): 5296 - 5305. [Abstract] [Full Text] [PDF]

				T. H. Schreiber, V. V. Deyev, J. D. Rosenblatt, and E. R. Podack Tumor-Induced Suppression of CTL Expansion and Subjugation by gp96-Ig Vaccination Cancer Res., March 1, 2009; 69(5): 2026 - 2033. [Abstract] [Full Text] [PDF]

				S. Kim, G. Buchlis, Z. G. Fridlender, J. Sun, V. Kapoor, G. Cheng, A. Haas, H. K. Cheung, X. Zhang, M. Corbley, et al. Systemic Blockade of Transforming Growth Factor-{beta} Signaling Augments the Efficacy of Immunogene Therapy Cancer Res., December 15, 2008; 68(24): 10247 - 10256. [Abstract] [Full Text] [PDF]

				L. Yang and H. L. Moses Transforming Growth Factor {beta}: Tumor Suppressor or Promoter? Are Host Immune Cells the Answer? Cancer Res., November 15, 2008; 68(22): 9107 - 9111. [Abstract] [Full Text] [PDF]

				Z. Liu, H. S. Noh, J. Chen, J. H. Kim, L. D. Falo Jr., and Z. You Potent Tumor-Specific Protection Ignited by Adoptively Transferred CD4+ T Cells J. Immunol., September 15, 2008; 181(6): 4363 - 4370. [Abstract] [Full Text] [PDF]

				J.-S. Nam, M. Terabe, M. Mamura, M.-J. Kang, H. Chae, C. Stuelten, E. Kohn, B. Tang, H. Sabzevari, M. R. Anver, et al. An Anti-Transforming Growth Factor {beta} Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments Cancer Res., May 15, 2008; 68(10): 3835 - 3843. [Abstract] [Full Text] [PDF]